Position in PTCT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$104,127,301
-$23,577,863 QoQ
Shares Held
1,528,362
-9.1% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 99.31861692452443.ToString("F0")%
Shared 0.ToString("F0")%
None 0.6813830754755745.ToString("F0")%
Common Shares in PTCT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026FMR LLC holds $49,682,018,247 across 354 Biotechnology names. PTCT ranks #77 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
14,579,166 | $4,823,808,652 | |
| 2 | ARGX |
Argenx SE
|
4,991,034 | $3,644,702,577 | |
| 3 | MRNA |
Moderna, Inc.
|
45,672,024 | $2,320,138,818 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
77,981,253 | $2,160,080,705 | |
| 5 | INSM |
INSMED Inc
|
13,160,167 | $2,151,950,504 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
24,556,637 | $1,843,957,869 | |
| 7 | RPRX |
Royalty Pharma plc
|
25,152,242 | $1,206,553,046 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,518,192 | $1,173,015,865 |
All Filings in PTCT
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $104,127,301 | 1,528,362 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $127,705,164 | 1,681,216 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $98,914,630 | 1,611,775 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $83,921,136 | 1,718,287 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $102,611,118 | 2,013,562 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $37,016,784 | 820,044 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $39,221,451 | 1,057,182 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $33,763,346 | 1,104,099 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $50,240,232 | 1,727,062 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $50,005,439 | 1,814,421 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $189,709,254 | 8,465,384 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $416,994,551 | 10,253,124 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $464,208,656 | 9,583,168 | Shares | Defined | 2023-08-11 | |
| 2022-12-31 | $411,560,617 | 10,782,306 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $538,703,427 | 10,731,144 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $428,675,528 | 10,700,837 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $400,229,778 | 10,727,145 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $422,384,601 | 10,604,685 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $394,081,098 | 10,590,731 | Shares | Defined | 2022-02-14 | |
| 2021-06-30 | $446,725,674 | 10,568,386 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $499,464,276 | 10,548,348 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $623,351,569 | 10,213,855 | Shares | Defined | 2021-02-08 | |
| 2020-09-30 | $473,763,376 | 10,133,976 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $339,691,308 | 6,694,744 | Shares | Defined | 2020-08-24 | |
| 2020-03-31 | $217,617,615 | 4,878,225 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||